You et al. [146] first found that coexpression of EGFR and HER2 correlated with poor survival among BC patients and that overexpression of HER2 promoted the invasion and proliferation of EGFR+ MDA-MB-231 cells. The gene discussed is EGFR; the disease is breast cancer.